Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Timothy Steiner

Orthopaedic Surgery Bloomington, IN Medical Doctor

NPI 1174742571 CMS profile 7717

583 S Clarizz Blvd, Bloomington, IN 47401

Open in the dashboard

General payments

$33,697

83 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Timothy Steiner of Bloomington, IN is reported in the CMS Open Payments database as having received $33,697 across 83 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,466 4
2024 General $9,870 22
2023 General $1,668 10
2022 General $12,070 36
2021 General $1,590 9
2020 General $32 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Timothy Steiner
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Timothy Steiner were reported at $8,466. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Timothy Steiner Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $32 $312 $75–$1,860 $114
2021 $1,590 $520 $117–$2,495 $132
2022 $12,070 $598 $128–$2,731 $149
2023 $1,668 $461 $128–$2,264 $160
2024 $9,870 $497 $134–$2,475 $164
2025 $8,466 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Medical Device Business Services, Inc. $20,743 24 payments
  2. DePuy Synthes Products, Inc. $7,286 7 payments
  3. Stryker Corporation $3,281 29 payments
  4. Encore Medical, LP $1,392 6 payments
  5. DePuy Synthes Sales Inc. $913 13 payments
  6. Integra LifeSciences Corporation $30 1 payment
  7. Merck Sharp & Dohme Corporation $30 2 payments
  8. Zimmer Biomet Holdings, Inc. $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $23,401 4 payments
  2. Travel and Lodging $7,307 23 payments
  3. Food and Beverage $2,989 56 payments
Products named General payments · program years 2020–2025
  1. RIGIDLOOP $1,783 10 payments
  2. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $1,434 12 payments
  3. DJO SURGICAL Joint Implants $1,132 4 payments
  4. Mitek $1,080 5 payments
  5. ACTISHIELD $891 1 payment
  6. DJO SURGICAL Joint Implants $689 1 payment
  7. DJO SURGICAL Joint Implants $604 4 payments
  8. DYNACORD $356 5 payments
  9. DJO SURGICAL Joint Implants $344 2 payments
  10. HEALIX KNOTLESS PEEK $213 2 payments
  11. Other $1,295 35 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

145

Median for Orthopedic Surgery: 203

Drug cost

$828

Median for Orthopedic Surgery: $1,433

Branded share of claims

31%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Mupirocin Generic 77 $460
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $184
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 22 $169
Amoxicillin Generic 23 $15

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$103,021

Of which drugs: $220

Medicare patients

250

Average age 74

Services billed

1,085

153 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 38%
Diabetes 32%
Ischemic heart disease 26%
Chronic kidney disease 25%
Atrial fibrillation 22%
Heart failure 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 38 304 $220

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

83 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record